Literature DB >> 8450575

The impact of gender on clinical characteristics and outcome in alcohol withdrawal.

P G O'Connor1, R I Horwitz, L D Gottlieb, M L Kraus, S R Segal.   

Abstract

Few studies have compared the social and clinical features of alcoholism for women and men, and none has focused on patients entering treatment for withdrawal. We investigated the role of gender by analyzing the data for 179 patients (34 women, 145 men) who underwent outpatient withdrawal. Our analysis focused on two questions: 1) How do women and men compare in terms of baseline social and clinical features? and 2) Do women and men have similar treatment outcomes in alcohol withdrawal? Baseline sociodemographic features revealed that women were more likely to be poor (90% vs. 71%, p = .03) but less likely to be uninsured (32% vs. 51%, p = .05), homeless (6% vs. 20%, p = .05), or have legal problems (29% vs. 54%, p = .02). Surprisingly, women and men reported a similar mean daily alcohol intake (240 g vs. 243 g). Women reported a shorter duration of alcohol abuse prior to entering treatment (16.1 y vs. 19.1 y). Although women experienced a higher treatment failure rate (53% vs. 43%), this difference is not significant. Our analysis highlights gender similarities and differences among patients entering treatment for withdrawal. We conclude that women and men have similar treatment outcomes in the management of alcohol withdrawal.

Entities:  

Mesh:

Year:  1993        PMID: 8450575     DOI: 10.1016/0740-5472(93)90099-n

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  2 in total

1.  Gender differences among Alaska Native people seeking alcohol withdrawal treatment.

Authors:  Ursula Running Bear; Janette Beals; Douglas K Novins; Spero M Manson
Journal:  Subst Abus       Date:  2016 Apr-Jun       Impact factor: 3.716

2.  Alcoholism in women: is it different in onset and outcome compared to men?

Authors:  Alexander Diehl; Bernhard Croissant; Anil Batra; Götz Mundle; Helmut Nakovics; Karl Mann
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-07-14       Impact factor: 5.270

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.